A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Restless Legs Syndrome

Interventions

DRUG

GEn 1200mg

1200 mg of Gen administered as a single dose

DRUG

Gen 6000 mg

6000 mg of Gen administered as a single dose

DRUG

GEn Placebo

Placebo to match GEn Tablets

DRUG

Moxifloxacin Placebo

Placebo to match Moxifloxacin

DRUG

Moxifloxacin

400 mg Moxifloxacin administered as a single dose

Trial Locations (1)

GSK Investigational Site, Austin

All Listed Sponsors

lead

XenoPort, Inc.

INDUSTRY

NCT01516372 - A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy Volunteers | Biotech Hunter | Biotech Hunter